Safety profile of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: long-term interim results from the ENDORSE extension study

被引：0
|
作者：
Pozzilli, C. [1 ]
Phillips, J. T. [2 ]
Fox, R. J. [3 ]
Selmaj, K. [4 ]
Zhang, R. [5 ]
Novas, M. [5 ]
Sweetser, M. T. [5 ]
Viglietta, V. [5 ]
Gold, R. [6 ]
机构：
[1] Univ Roma La Sapienza, Dept Neurol & Psychiat, Fac Med, I-00185 Rome, Italy
[2] Baylor Inst Immunol Res, Multiple Sclerosis Program, Dallas, TX USA
[3] Cleveland Clin, Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH 44106 USA
[4] Med Univ Lodz, Dept Neurol, Lodz, Poland
[5] Biogen Idec Inc, Cambridge, MA USA
[6] Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, Bochum, Germany
来源：
JOURNAL OF NEUROLOGY | 2014年 / 261卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
PP4153
引用
收藏
页码：S439 / S439
页数：1
相关论文
共 50 条
  • [1] Safety profile of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: long-term interim results from the ENDORSE extension study
    Pozzilli, C.
    Phillips, J. T.
    Fox, R. J.
    Selmaj, K.
    Zhang, R.
    Novas, M.
    Sweetser, M. T.
    Viglietta, V.
    Gold, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 678 - 678
  • [2] Safety of Delayed-release Dimethyl Fumarate in Relapsing-Remitting Multiple Sclerosis Patients from ENDORSE: Seven-Year Interim Results
    Pozzilli, Carlo
    Phillips, J. Theodore
    Fox, Robert J.
    Prada, Claudia
    Yang, Lili
    Taylor, Catherine
    Fay, Monica
    NEUROLOGY, 2017, 88
  • [3] Safety profile of BG-12 (dimethyl fumarate) in relapsing remitting multiple sclerosis: long-term interim results from the ENDORSE extension study
    Phillips, J. T.
    Fox, R. J.
    Selmaj, K.
    Yang, M.
    Zhang, R.
    Novas, M.
    Sweetser, M. T.
    Viglietta, V.
    Gold, R.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 457 - 457
  • [4] Long-term safety and efficacy of delayed-release dimethyl fumarate in paediatric patients with relapsing-remitting multiple sclerosis: a long-term extension of the FOCUS study
    Alroughani, R.
    Huppke, P.
    Pultz, J.
    Parks, B.
    Beynon, V.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 147 - 148
  • [5] Long-term effects of delayed-release dimethyl fumarate in multiple sclerosis: Interim analysis of ENDORSE, a randomized extension study
    Gold, Ralf
    Arnold, Douglas L.
    Bar-Or, Amit
    Hutchinson, Michael
    Kappos, Ludwig
    Havrdova, Eva
    MacManus, David G.
    Yousry, Tarek A.
    Pozzilli, Carlo
    Selmaj, Krysztof
    Sweetser, Marianne T.
    Zhang, Ray
    Yang, Minhua
    Potts, James
    Novas, Mark
    Miller, David H.
    Kurukulasuriya, Nuwan C.
    Fox, Robert J.
    Phillips, Theodore J.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (02) : 253 - 265
  • [6] Rate of brain volume loss under long-term delayed-release dimethyl fumarate treatment in relapsing-remitting multiple sclerosis patients: results from the ENDORSE study
    Kappos, L.
    Fox, R. J.
    Gold, R.
    Arnold, D. L.
    Potts, J.
    Zhang, A.
    Kurukulasuriya, N. C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 48 - 48
  • [7] Long-term safety and tolerability of oral BG-12 (dimethyl fumarate) in relapsing-remitting multiple sclerosis: interim results from ENDORSE
    Phillips, J. T.
    Fox, R. J.
    Selmaj, K.
    Raghupathi, K.
    O'Gorman, J.
    Novas, M.
    Sweetser, M. T.
    Viglietta, V.
    Dawson, K. T.
    Gold, R.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 517 - 518
  • [8] Sustained low rate of brain volume loss with long-term delayed-release dimethyl fumarate treatment in relapsing-remitting multiple sclerosis patients: results from the ENDORSE study
    Miller, D.
    Yousry, T.
    Fox, R. J.
    Gold, R.
    Arnold, D. L.
    Potts, J.
    Marantz, J. L.
    Kappos, L.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 550 - 551
  • [9] Long-term follow-up of the safety of delayed-release dimethyl fumarate in RRMS: interim results from the ENDORSE extension study
    Pozzilli, C.
    Phillips, J. T.
    Fox, R. J.
    Selmaj, K.
    Zhang, R.
    Novas, M.
    Sweetser, M. T.
    Gold, R.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 96 - 97
  • [10] Long-term follow-up of the safety of delayed-release dimethyl fumarate in RRMS: interim results from the ENDORSE extension study
    Pozzilli, C.
    Phillips, J. T.
    Fox, R. J.
    Selmaj, K.
    Zhang, R.
    Novas, M.
    Sweetser, M. T.
    Gold, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 709 - 709
12345